{
  "id": 20313122,
  "title": "MRD Ready to Guide Multiple Myeloma Treatment Decisions?",
  "url": "https://urgent.news/2026/11/16/mrd-ready-to-guide-multiple-myeloma-treatment-decisions",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T17:31:11.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/meetingcoverage/ashroundtablemm/123900"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- As minimal residual disease (MRD) testing becomes increasingly important in multiple myeloma care, questions remain about whether MRD negativity should guide decisions on treatment duration and the need for stem cell transplantation...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}